Cargando…
Oral perfluorooctane sulfonate (PFOS) lessens tumor development in the APC(min) mouse model of spontaneous familial adenomatous polyposis
BACKGROUND: Colorectal cancer is the second most common cause of cancer deaths for both men and women, and the third most common cause of cancer in the U.S. Toxicity of current chemotherapeutic agents for colorectal cancer, and emergence of drug resistance underscore the need to develop new, potenti...
Autores principales: | Wimsatt, Jeffrey, Villers, Meghan, Thomas, Laurel, Kamarec, Stacey, Montgomery, Caitlin, Yeung, Leo W. Y., Hu, Yanqing, Innes, Kim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5143440/ https://www.ncbi.nlm.nih.gov/pubmed/27927180 http://dx.doi.org/10.1186/s12885-016-2861-5 |
Ejemplares similares
-
Inverse association of colorectal cancer prevalence to serum levels of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in a large Appalachian population
por: Innes, Kim E, et al.
Publicado: (2014) -
Nephrotoxicity of perfluorooctane sulfonate (PFOS)—effect on transcription and epigenetic factors
por: Wen, Yi, et al.
Publicado: (2022) -
Assessment of a mouse xenograft model of primary colorectal cancer with special reference to perfluorooctane sulfonate
por: Wimsatt, Jeffrey H., et al.
Publicado: (2018) -
Alteration to Dopaminergic Synapses Following Exposure to Perfluorooctane Sulfonate (PFOS), in Vitro and in Vivo
por: Patel, Rahul, et al.
Publicado: (2016) -
The role of perfluorooctane sulfonic acid (PFOS) exposure in inflammation of intestinal tissues and intestinal carcinogenesis
por: Durham, Jerika, et al.
Publicado: (2023)